Killing of a target cell by immune cells when directed by a specific antibody to the target. A positive aspect if the antibody is designed to kill cancer cells. A negative aspect if the antibody is designed for other functions. Measured by radioactive 51Cr release from the target or by other methods.

« Back to Glossary Index